
Stratum Biosciences offers therapies that cross the skin barrier to reach targeted tissues. It uses an AI-driven platform and biomarker discovery to design active ingredients and validate formulations. Core technology includes SkinSync ingredients, real skin samples, and laboratory experiments to test and optimize compounds. The company operates in dermatology, serving skincare and pharmaceutical development through partnerships and collaborations. The platform aims to scale in B2B markets by enabling partners to bring new skin therapies and formulations to market.

Stratum Biosciences offers therapies that cross the skin barrier to reach targeted tissues. It uses an AI-driven platform and biomarker discovery to design active ingredients and validate formulations. Core technology includes SkinSync ingredients, real skin samples, and laboratory experiments to test and optimize compounds. The company operates in dermatology, serving skincare and pharmaceutical development through partnerships and collaborations. The platform aims to scale in B2B markets by enabling partners to bring new skin therapies and formulations to market.